Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Azitra Inc (AZTR)

Azitra Inc (AZTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,158
  • Shares Outstanding, K 10,741
  • Annual Sales, $ 10 K
  • Annual Income, $ -8,970 K
  • EBIT $ -11 M
  • EBITDA $ -10 M
  • 60-Month Beta -1.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.51
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.08
  • Most Recent Earnings $-0.67 on 11/12/25
  • Next Earnings Date 02/23/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.37
  • Number of Estimates 1
  • High Estimate -0.37
  • Low Estimate -0.37
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1874 +6.72%
on 02/10/26
0.3616 -44.69%
on 01/16/26
-0.0900 (-31.03%)
since 01/09/26
3-Month
0.1874 +6.72%
on 02/10/26
0.4297 -53.46%
on 11/13/25
-0.2008 (-50.10%)
since 11/10/25
52-Week
0.1874 +6.72%
on 02/10/26
2.9704 -93.27%
on 02/18/25
-2.0218 (-91.00%)
since 02/10/25

Most Recent Stories

More News
Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

BRANFORD, Conn. , Feb. 6, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology,...

AZTR : 0.1990 (-0.95%)
Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

BRANFORD, Conn. , Jan. 7, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision...

AZTR : 0.1990 (-0.95%)
Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

BRANFORD, Conn. , Dec. 17, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology,...

AZTR : 0.1990 (-0.95%)
Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules

BRANFORD, Conn. , Nov. 24, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision...

AZTR : 0.1990 (-0.95%)
Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates

BRANFORD, Conn. , Nov. 12, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision...

AZTR : 0.1990 (-0.95%)
Azitra, Inc. Addresses False Report Regarding Sale of Securities

BRANFORD, Conn. , Nov. 7, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology,...

AZTR : 0.1990 (-0.95%)
Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris

ATR-01, which uses a filaggrin-secreting strain of S. epidermidis , is in preclinical development for ichthyosis vulgaris

AZTR : 0.1990 (-0.95%)
Azitra Inc Faces NYSE Compliance Deadline Notice

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Azitra Inc...

AZTR : 0.1990 (-0.95%)
Azitra Receives Notice of Non-Compliance from NYSE American

BRANFORD, Conn. , Oct. 3, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology,...

AZTR : 0.1990 (-0.95%)
Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

BRANFORD, Conn. , Sept. 4, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision...

AZTR : 0.1990 (-0.95%)

Business Summary

Azitra Inc. is an early-stage clinical biopharmaceutical company. It focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. Azitra Inc. is based in BRANFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 0.2294
2nd Resistance Point 0.2214
1st Resistance Point 0.2111
Last Price 0.1990
1st Support Level 0.1928
2nd Support Level 0.1848
3rd Support Level 0.1745

See More

52-Week High 2.9704
Fibonacci 61.8% 1.9073
Fibonacci 50% 1.5789
Fibonacci 38.2% 1.2505
Last Price 0.1990
52-Week Low 0.1874

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar